Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: National Cancer Institute (NCI)
Condition: Stage IV Melanoma, Stage III Melanoma, Recurrent Melanoma
NCT00019890
Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Completed No Results Found Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.